VIOLIN Logo
VIOLIN Banner
Search: for Help
CanVaxKB Home
Introduction
Statistics
News and Updates
CanVaxKB Query
Data Submission
Data Exchange
Data Download
Documentation
Links
Acknowledgements
FAQs
Disclaimer
Contact Us
UMMS Logo

Vaccine Detail

Allogeneic Tumor Cell Vaccine
Vaccine Information
  • Vaccine Ontology ID: VO_0007233
  • Type: Other
  • Status: Clinical trial
  • Host Species for Licensed Use: Human
  • Host Species as Laboratory Animal Model: Human
  • Preparation: (Flores et al., 2007; Kelsen et al., 2007; Manegold and Thatcher, 2007)
  • Description: A vaccine composed of tumor cells isolated from the tumor of one patient, killed and processed, and administered to another patient to stimulate cytotoxic immune responses to a similar tumor cell type. The cells found in this type of whole-cell vaccine express many cell-surface tumor-associated antigens. This vaccine is frequently administered with an adjuvant immunostimulant. (NCIT_C1983).

    This vaccine has been used in multiple cancer types including pancreatic, multiple myeloma, breast cancer. https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/allogeneic-tumor-cell-vaccine
Host Response
References
Flores et al., 2007: Flores RM, Zakowski M, Venkatraman E, Krug L, Rosenzweig K, Dycoco J, Lee C, Yeoh C, Bains M, Rusch V. Prognostic factors in the treatment of malignant pleural mesothelioma at a large tertiary referral center. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2007; 2(10); 957-965. [PubMed: 17909360].
Kelsen et al., 2007: Kelsen DP, Winter KA, Gunderson LL, Mortimer J, Estes NC, Haller DG, Ajani JA, Kocha W, Minsky BD, Roth JA, Willett CG. Long-term results of RTOG trial 8911 (USA Intergroup 113): a random assignment trial comparison of chemotherapy followed by surgery compared with surgery alone for esophageal cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2007; 25(24); 3719-3725. [PubMed: 17704421].
Manegold and Thatcher, 2007: Manegold C, Thatcher N. Survival improvement in thoracic cancer: progress from the last decade and beyond. Lung cancer (Amsterdam, Netherlands). 2007; 57 Suppl 2; S3-5. [PubMed: 17686443].
NCIT_C1983: [https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C1983]